Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

JinLiDa granules alleviates cardiac hypertrophy and inflammation in diabetic cardiomyopathy by regulating TP53

10 May 2024

Abstract excerpt

BACKGROUND: JinLiDa granules (JLD) is a traditional Chinese medicine (TCM) used to treat type 2 diabetes mellitus with Qi and Yin deficiency. Clinical evidence has shown that JLD can alleviate diabetic cardiomyopathy, but the exact mechanism is not yet clear. PURPOSE: The purpose of this study was to examine the potential role and mechanism of JLD in the treatment of diabetic cardiomyopathy through network...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiac Fibrosis and Remodeling
Share to Cardiomyopathy and Myosin Studies
Share to Cardiovascular Function and Risk Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38759318
DOI: 10.1016/j.phymed.2024.155659

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

JinLiDa granules alleviates cardiac hypertrophy and inflammation in diabetic cardiomyopathy by regulating TP53PMID 38759318Read ↗

Jinlida granules alleviate podocyte apoptosis and mitochondrial dysfunction via the AMPK/PGC‑1α pathway in diabetic nephropathySemantic proximity Read ↗

Novel Insights Into the Pathogenesis of Diabetic Cardiomyopathy and Pharmacological StrategiesSemantic proximity Read ↗

Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAsSemantic proximity Read ↗

Network Pharmacology and Experimental Verification Reveal an Protective Role of Jiedu Tongluo Tiaogan Formula on INS-1 Cells and HepG2 Cells From High Glucose-mediated Injury via the PI3K/Akt PathwaysSemantic proximity Read ↗

Differentially expressed miRNAs in db mouse induced diabetic cardiomyopathySemantic proximity Read ↗

Potential Mechanisms of Triptolide against Diabetic Cardiomyopathy Based on Network Pharmacology Analysis and Molecular DockingSemantic proximity Read ↗

Pyroptosis and Its Regulation in Diabetic CardiomyopathySemantic proximity Read ↗

Analysis of differentially expressed genes related to the development of diabetic cardiomyopathy in the myocardium of type-2 diabetic ratsSemantic proximity Read ↗

Gut microbiota: A new therapeutic target for diabetic cardiomyopathySemantic proximity Read ↗

Gastrodin attenuates diabetic cardiomyopathy characterised by myocardial fibrosis by inhibiting the KLK8-PAR1 signalling axisSemantic proximity Read ↗

Role of pyroptosis in diabetic cardiomyopathy: an updated reviewSemantic proximity Read ↗

Prohibitin overexpression improves myocardial function in diabetic cardiomyopathySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.